Primary immunodeficiency diseases in the newborn

Area of Science:

• Immunology
• Neonatal Medicine
• Genetics

Background:

• Neonatal immune system is anatomically mature but immunologically naive, with reduced pro-inflammatory responses and cell-mediated immunity.
• Newborns are susceptible to infections due to immature immune defenses, despite innate immunity and maternal antibody transfer.
• Primary immunodeficiency diseases (PIDs) presenting in the neonatal period pose significant life-threatening risks.

Purpose of the Study:

• To review the unique immunological characteristics of newborns.
• To discuss the risk factors, clinical features, and laboratory evaluation of common PIDs in neonates.
• To provide an overview of various PIDs affecting newborns, including antibody deficiencies, combined immunodeficiencies, phagocytic disorders, and complement deficiencies.

Main Methods:

• Literature review of neonatal immunology and primary immunodeficiency diseases.
• Synthesis of information on risk factors, clinical presentations, and diagnostic methods for neonatal PIDs.
• Categorization and brief description of common PIDs in newborns.

Main Results:

• Neonates possess a unique immune system balancing susceptibility and protection.
• Common PIDs in newborns encompass a range of disorders affecting different arms of the immune system.
• Early diagnosis and management of PIDs are crucial due to their potential severity.

Conclusions:

• Understanding neonatal immunity is key to recognizing and managing PIDs.
• The complexity and growing number of PIDs necessitate comprehensive diagnostic strategies.
• This review highlights the importance of evaluating PIDs in at-risk neonates for timely intervention.